SCHEMBL9070549

SCHEMBL9070549

COc1cccc(-c2[c]cccc2N(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 3/20 0.41
DYRK1A Q13627 1/20 0.41
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C19 P33261 3/20 0.40
USP2 O75604 2/20 0.40
MAPK1 P28482 2/20 0.40
CYP2C9 P11712 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
TSHR P16473 1/20 0.40
HIF1A Q16665 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2A6 P11509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843209 0.80 DYRK1A (0.45) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL5506754 0.80 DYRK1A (0.45) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL3411791 0.80 CYP1A1 (0.45) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL28196403 0.78 SLC6A4 (0.41) CLK4DYRK1ACYP2D6ALDH1A1HSD17B2
SCHEMBL2377417 0.78 HDAC4 (0.55) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL9430884 0.78 DYRK1A (0.44) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL9716169 0.78 TAAR1 (0.41) HSD17B2GAAHSD17B1
SCHEMBL12472636 0.72 NPC1 (0.51) ALDH1A1LMNAHDAC4HDAC8MAOB
SCHEMBL1274110 0.72 DYRK1A (0.40) CLK4DYRK1ACYP1A2CYP3A4CYP2D6
SCHEMBL18585090 0.72 KDM4E (0.31) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0507854-B1 METHODS FOR DIAGNOSING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN SYMEX CORP (US) 1996-11-27 EP claimed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed